High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma.

Autor:	Grissenberger, Sarah1 (AUTHOR), Sturtzel, Caterina1,2 (AUTHOR), Wenninger-Weinzierl, Andrea1,2 (AUTHOR), Radic-Sarikas, Branka1,3 (AUTHOR), Scheuringer, Eva1,2 (AUTHOR), Bierbaumer, Lisa1 (AUTHOR), Etienne, Vesnie4 (AUTHOR), Némati, Fariba4 (AUTHOR), Pascoal, Susana1,2 (AUTHOR), Tötzl, Marcus1 (AUTHOR), Tomazou, Eleni M.1 (AUTHOR), Metzelder, Martin3 (AUTHOR), Putz, Eva M.1 (AUTHOR), Decaudin, Didier4,5 (AUTHOR), Delattre, Olivier6 (AUTHOR), Surdez, Didier6,7 (AUTHOR), Kovar, Heinrich1,8 (AUTHOR), Halbritter, Florian1 (AUTHOR), Distel, Martin1,2 (AUTHOR) martin.distel@ccri.at, Tomazou, Eleni1 (AUTHOR)
Zdroj:	Cancer Letters. Feb2023, Vol. 554, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect